Literature DB >> 24788030

Translation and cross-cultural adaptation of the Scleroderma Health Assessment Questionnaire to Brazilian Portuguese.

Aline Cristina Orlandi1, Fernanda Pontes Cardoso1, Lucas Macedo Santos1, Vaneska da Graça Cruz1, Anamaria Jones1, Cristiane Kyser1, Jamil Natour1.   

Abstract

CONTEXT AND
OBJECTIVE: Systemic sclerosis is an autoimmune disease characterized by abnormalities of vascularization that may cause fibrosis of the skin and other organs and lead to dysfunction. It is therefore essential to have tools capable of evaluating function in individuals with this condition. The aim of this study was to translate the Scleroderma Health Assessment Questionnaire (SHAQ) into Portuguese, adapt it to Brazilian culture and test its validity and reliability. DESIGN AND
SETTING: The validation of SHAQ followed internationally accepted methodology, and was performed in university outpatient clinics.
METHODS: SHAQ was translated into Portuguese and back-translated. In the cultural adaptation phase, it was applied to 20 outpatients. Items not understood by 20% of the patients were modified and applied to another 20 outpatients. Twenty patients were interviewed on two different occasions to determine the validity and reliability of the questionnaire: two interviewers on the first occasion and one interviewer 14 days later. To determine the external validity, comparisons were made with Health Assessment Questionnaire (HAQ), Disabilities of the Arm, Shoulder and Hand (DASH) and short form-36 (SF-36).
RESULTS: In the interobserver evaluation, Pearson's correlation coefficient and the intraclass correlation coefficient were both 0.967. In the intraobserver evaluation, Pearson's correlation coefficient was 0.735 and the intraclass correlation coefficient was 0.687. Regarding external validity, SHAQ scores were statistically correlated with all measurements, except the general health domain of SF-36 and the work-related score (Q2) of DASH.
CONCLUSION: The Brazilian version of SHAQ proved to be valid and reliable for assessing function in patients with diffuse systemic sclerosis.

Entities:  

Mesh:

Year:  2014        PMID: 24788030     DOI: 10.1590/1516-3180.2014.1323621

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  1 in total

1.  Nutritional risk in patients with systemic sclerosis.

Authors:  Aysa César Pinheiro; Letticia Cristina Santos Cardozo Roque; Rafaela Silva Guimarães Gonçalves; Angela Luzia Branco Pinto Duarte; Andréa Tavares Dantas
Journal:  Clin Rheumatol       Date:  2019-11-23       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.